PNOC 001: Phase II Study of Everolimus for Recurrent or Progressive Low-grade Gliomas in Children
Phase of Trial: Phase II
Latest Information Update: 23 Nov 2017
At a glance
- Drugs Everolimus (Primary)
- Indications Astrocytoma; Glioma
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 08 May 2017 Planned primary completion date changed from 1 Mar 2017 to 1 Mar 2019.
- 08 May 2017 Status changed from active, no longer recruiting to recruiting.